Showing results (31-40 of 3,322) with videos related to
Sort By:
Pageof 333
Expert Opinion on Drug Metabolism & Toxicology|July 26, 2006
Two-dimensional gels for toxicological drug discovery applicationsFrank A Witzmann, Matthew R RichardsonInternational Journal of Biomedical Nanoscience and Nanotechnology|November 15, 2013
Nanoparticle toxicity by the gastrointestinal route: evidence and knowledge gapsIngrid L Bergin, Frank A WitzmannElectroencephalography and Clinical Neurophysiology|July 1, 1986
Somatosensory evoked potentials (SSEPs) in various groups of cerebro-vascular ischaemic diseaseF Reisecker, A Witzmann, E DeisenhammerNeurochirurgia|November 1, 1981
[Glioblastoma multiforme developing after a gunshot injury of the brain (author's transl)]A Witzmann, K Jellinger, R WeissSurgical Neurology|December 26, 2001
Ocular manifestations of sphenoid mucoceles: clinical features and neurosurgical management of three cases and review of the literatureN Hejazi, A Witzmann, W HasslerThe Pharmacogenomics Journal|May 15, 2003
Pharmacoproteomics in drug developmentFrank A Witzmann, Raymond A GrantProteomics|April 23, 2005
A "de-streaking" method for two-dimensional electrophoresis using the reducing agent tris(2-carboxyethyl)-phosphine hydrochloride and alkylating agent vinylpyridineFengju Bai, Sheng Liu, Frank A WitzmannInternational Journal of Proteomics|February 13, 2013
Issues and applications in label-free quantitative mass spectrometryXianyin Lai, Lianshui Wang, Frank A WitzmannNanomedicine : Nanotechnology, Biology, and Medicine|February 13, 2007
Multi-walled carbon nanotube exposure alters protein expression in human keratinocytesFrank A Witzmann, Nancy A Monteiro-RiviereApplied and Theoretical Electrophoresis : the Official Journal of the International Electrophoresis Society|January 1, 1995
Comparative 2D-electrophoretic mapping of human and rodent hepatic stress proteins as potential biomarkersF A Witzmann, C Fultz, J LipscombPageof 333